Carlyle Group Inc.

Institutional InvestorSimilar funds →SEC EDGAR: CIK 1527166
Institutional-grade research for retail investors
Email me the moment this fund files its next 13F

13F Reported Value

$10.0B

Holdings

19

Latest Filing

2026-06-30

Filing Quarter

Q2 2026

Portfolio Overview

Carlyle Group Inc. disclosed 19 positions worth $10.0B in its Form 13F-HR for Q2 2026, led by $MDLN (Medline Inc.) at 73.8% of the equity portfolio, followed by $SARO and $PHAT. During the quarter the fund opened 3 new positions and exited 4 — including a new stake in $REPX and a full exit from $CUBE. The portfolio is most concentrated in Healthcare (74.2% of disclosed assets). All figures are sourced directly from Carlyle Group Inc.’s Form 13F-HR filing with the SEC under CIK 1527166.

Sector Allocation

HealthcareIndustrialsReal EstateTechnologyConsumer StaplesEnergy

AUM History

Top Equity Holdings by Value

Quarterly Activity — Q2 2026

Click any card to unlock

Top Holdings

AI Quality Scored

Unlock AI quality scores for every holding

32-signal composite ranking on each of Carlyle Group Inc.'s 19 positions.

Showing top 10 of 19 holdings.

Sector Allocation

Healthcare

$7.4B

Industrials

$2.5B

Real Estate

$20.0M

Technology

$17.3M

Consumer Staples

$1.2M

Energy

$818,054

Financials

$474,625

Full HoldingsCarlyle Group Inc. (Q2 2026)

All 19 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.

TickerCompanyValue
MDLN$MDLNMedline Inc.$7.4B
SARO$SAROStandardAero, Inc.$2.5B
PHAT$PHATPhathom Pharmaceuticals, Inc.$37.9M
INVH$INVHInvitation Homes Inc.$20.0M
PONY$PONYPony AI Inc.$16.4M
GETY$GETYGetty Images Holdings, Inc.$5.4M
SPRB$SPRBSPRUCE BIOSCIENCES, INC.$2.1M
SPWR$SPWRSunPower Inc.$1.6M
ACET$ACETAdicet Bio, Inc.$1.6M
FWRD$FWRDFORWARD AIR CORP$1.4M
OKUR$OKUROnKure Therapeutics, Inc.$1.2M
DNUT$DNUTKrispy Kreme, Inc.$1.2M
FIXX$FIXXQ32 Bio Inc.$769,020
REPX$REPXRiley Exploration Permian, Inc.$530,387
NBIS$NBISNebius Group N.V.$509,810
HOOD$HOODRobinhood Markets, Inc.$474,625
JSPR$JSPRJasper Therapeutics, Inc.$448,866
NABL$NABLN-able, Inc.$343,996
METC$METCRamaco Resources, Inc.$287,667

New Positions (3)

REPX$REPX Riley Exploration Permian, Inc.$530,387
NBIS$NBIS Nebius Group N.V.$509,810
METC$METC Ramaco Resources, Inc.$287,667

Exited Positions (4)

CUBE$CUBE CubeSmart
HTFL$HTFL Heartflow, Inc.
SYRE$SYRE Spyre Therapeutics, Inc.
XCUR$XCUR EXICURE, INC.

Browse Top Institutional Investors

13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.

to search all 8,700+ institutional filers.

Available Analysis

13F Pro tracks comprehensive institutional data for Carlyle Group Inc. including:

Full 13F portfolio with all holdings
Quarter-over-quarter position changes
Accumulation & distribution patterns
Sector allocation breakdown
Historical portfolio evolution
New positions & complete exits
Concentration analysis
Peer comparison with similar funds
AI-powered portfolio insights

Track Carlyle Group Inc.'s Full Portfolio

See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for Carlyle Group Inc. and 8,700+ other institutional investors.

View Pricing

Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

AI-Powered Hedge Fund Analysis: Carlyle Group Inc.

13F Pro is an AI hedge fund tracker and stock research platform. For Carlyle Group Inc. (SEC CIK: 1527166), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.

Every holding in Carlyle Group Inc.'s portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.